Peer-reviewedCC BYBMJ open respiratory research
Cost-effectiveness of anti-inflammatory reliever (AIR) or maintenance and reliever therapy (MART) for mild to moderate asthma: a systematic review.
7 affiliations
- 1Department of Paediatrics and Child Health, School of Medicine, University of KwaZulu-Natal, Durban, South Africa [email protected].
- 2Department of Paediatrics and Child Health, School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
- 3Cambridge Africa, Department of Pathology, University of Cambridge, Cambridge, UK.
- 4Respiratory Department, Aintree University Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
- 5School of Accounting, Economics and Finance, University of KwaZulu-Natal, Durban, South Africa.
- 6Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa.
- 7Africa Health Research Institute, Mtubatuba, South Africa.
Related
- The Efficacy and Safety of Etrasimod for the Induction and Maintenance of Remission in Moderate to Severe Ulcerative Colitis: An Updated Systematic Review and Meta-Analysis of Randomised Controlled Trials
- Effectiveness of mobile health interventions for promoting moderate-to-vigorous physical activity in children and adolescents: systematic review and meta-analysis.
- Implementation of the National Asthma Guidelines in New Zealand: a retrospective patient-level study of the change to anti-inflammatory reliever therapy in 324,972 patients
- Cost-effectiveness of iStent-based trabecular micro-bypass stenting combined with cataract surgery in mild-to-moderate open-angle glaucoma: a systematic review of analytic perspectives and time horizons.
- Comparative Effectiveness of Individual DPP-4 Inhibitors on Kidney Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: A Target Trial Emulation
BibTeX
@article{ndimande2026costeffectiveness,
title = {{Cost-effectiveness of anti-inflammatory reliever (AIR) or maintenance and reliever therapy (MART) for mild to moderate asthma: a systematic review.}},
author = {Nqobile Ndimande and Kevin Mortimer and Marie Stolbrink and Josue Mbonigaba and Nicola Marozva and Refiloe Masekela},
journal = {BMJ open respiratory research},
year = {2026},
month = oct,
doi = {10.1136/bmjresp-2026-004148},
url = {https://europepmc.org/article/MED/42850063},
note = {CC BY},
}
RIS
TY - JOUR
TI - Cost-effectiveness of anti-inflammatory reliever (AIR) or maintenance and reliever therapy (MART) for mild to moderate asthma: a systematic review.
AU - Nqobile Ndimande
AU - Kevin Mortimer
AU - Marie Stolbrink
AU - Josue Mbonigaba
AU - Nicola Marozva
AU - Refiloe Masekela
PY - 2026
DA - 2026/10/08
JO - BMJ open respiratory research
DO - 10.1136/bmjresp-2026-004148
UR - https://europepmc.org/article/MED/42850063
SN - 2052-4439
ER -